Skip to main content

iShares S&P Mid-Cap 400 Growth ETF ETF

  • IJK
  • US equity
  • Mid cap, growth
  • BlackRock
  • Tracks the S&P Mid Cap 400 Growth
$107.22−1.26%Close 16 Nov 2026 · Holdings as of 12 Nov 2026
Net assets
$10.5B
Expense ratio
0.16%
Cost on $10,000
$16.00 a year
Holdings
248
Ten largest
12.8%
Return · 1 year
+13.5%
52-week range$91.45 — $119.11

Price close 16 Nov 2026

−2.4%1 monthHigh $110.37Low $104.55
$104$106$108$110$11223 Oct29 Oct4 Nov10 Nov16 Nov
−2.8%6 monthsHigh $119.11Low $104.55
$100$105$110$115$1204 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+10.7%year to dateHigh $119.11Low $97.22
$90$100$110$12011 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+13.5%1 yearHigh $119.11Low $91.45
$90$100$110$120Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+46.1%3 yearsHigh $119.11Low $72.67
$60$80$100$120Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+141%10 yearsHigh $119.11Low $38.48
$25$50$75$100$125Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26
1M
−2.4%
6M
−2.8%
YTD
+10.7%
1Y
+13.5%
3Y
+46.1%
10Y
+141%

Price change over each period, from daily closes; dividends not included.

iShares S&P Mid-Cap 400 Growth ETF (IJK) is a mid cap, growth US equity exchange-traded fund from BlackRock, tracking the S&P Mid Cap 400 Growth Index.

It charges 0.16% a year — $16.00 on $10,000, and holds 248 positions, the ten largest 12.8% of the fund.

Its net assets were $10.5 billion on November 10, 2026; it is the 3rd largest of the 3 mid cap, growth funds among the 300 largest ETFs.

From the fund's prospectus and its latest holdings (12 Nov 2026), compiled and checked by AapWire.

Largest holdings 10 of 248 · 12 Nov 2026

iShares S&P Mid-Cap 400 Growth ETF largest holdings
HoldingWeightWeight bar
ATI ATI1.52%
Technipfmc PLC FTI1.49%
United Therapeutics UTHR1.49%
Tenet Healthcare Corp THC1.36%
XPO XPO1.30%
Royal Gold RGLD1.27%
Woodward WWD1.15%
ITT INC ITT1.13%
Nvent Electric PLC NVT1.10%
Curtiss Wright CW1.03%

Where the money is 100% of the stocks classified

iShares S&P Mid-Cap 400 Growth ETF sectors
Industrials30.2%
Health Care19.2%
Information Technology16.1%
Financials8.5%
Consumer Discretionary8.3%
Real Estate6.2%
Materials4.1%
Energy2.9%
Utilities2.0%
Consumer Staples1.4%
Communication Services1.2%

The eleven sectors of the company pages: an S&P 500 member counts in its index sector, any other holding in its industry's; shares of the stock that has a sector.

Countries as the fund reports them: US 99.0%, CA 1.0%.

Key facts

iShares S&P Mid-Cap 400 Growth ETF key facts
CategoryMid cap, growth · US equity
IssuerBlackRock
IndexS&P Mid Cap 400 Growth Index
Expense ratio0.16% · $16.00 a year on $10,000
Net assets$10.5B · 10 Nov 2026
Holdings248 · ten largest 12.8%
Legal formRegistered fund
Rank in category3 of 3 · by size, among the 300 largest ETFs

Total return by calendar year at net asset value, after costs

iShares S&P Mid-Cap 400 Growth ETF calendar-year returns
YearTotal return
20257.3%
202415.8%
202317.3%
2022-19.1%
202118.7%
202022.5%
201926.0%
2018-10.5%
201719.7%
201614.5%

From the prospectus filed 27 Jul 2026.

Questions

What is the expense ratio of IJK?

IJK's expense ratio is 0.16% a year, $16.00 on a $10,000 holding, from its latest prospectus.

What index does IJK track?

IJK tracks the S&P Mid Cap 400 Growth Index.

How many holdings does IJK have?

IJK held 248 positions on November 12, 2026.

What are IJK's largest holdings?

ATI (1.5%), Technipfmc PLC (1.5%), United Therapeutics (1.5%), Tenet Healthcare Corp (1.4%), XPO (1.3%).

Who issues IJK?

IJK is issued by BlackRock; it is a registered fund.

In the terminal

Everything on IJK: daily holdings, flows, premium or discount and every stock it holds.

  • Flows in and out of the fund, a week to a year
  • Premium or discount to net asset value
  • The same index for less, and peers by category
See plans

Other mid cap, growth funds

The fund's costs and returns are read from its prospectus, its positions from its latest report or its issuer's own file, and its category from what it holds and how it names itself. A figure that cannot be read is left blank. See data and methodology.